Internal Medicine, Hematology & Oncology · Munster, IN
NPI
1831176874
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
929 Ridge Rd, Suite 5
Munster, IN, 46321
Phone (219) 836-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
374,094 services
Medicare patients, 2024
595
Average age 75
Drug cost, 2024
$2.5M
721 prescriptions
Company payments, 2025
$3,833
From 51 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghassan M Jano was code J1756 (injection, iron sucrose, 1 mg), 69,600 times for 51 patients. In total Ghassan M Jano billed 374,094 services in 117 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 69,600 | 51 | $0.17 | $12K |
| J9025 Injection, azacitidine, 1 mg | Office | 59,175 | 13 | $0.29 | $17K |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 36,420 | 21 | $0.26 | $9,551 |
| J9299 Injection, nivolumab, 1 mg | Office | 27,560 | 11 | $24.54 | $676K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 26,917 | 27 | $44.61 | $1.2M |
| J9267 Injection, paclitaxel, 1 mg | Office | 11,149 | 12 | $0.08 | $891 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 8,349 | 37 | $5.72 | $48K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 6,900 | 40 | $0.07 | $499 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,228 | 64 | $0.09 | $546 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 5,368 | 14 | $0.22 | $1,204 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,880 | 41 | $0.70 | $2,727 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,640 | 22 | $35.31 | $129K |
| 36415 Venipuncture Blood Collection | Office | 2,137 | 336 | $5.82 | $12K |
| 85025 Blood Count | Office | 2,088 | 326 | $7.47 | $16K |
| 96367 Intravenous Infusion, Hydration | Office | 1,518 | 88 | $20.39 | $31K |
By year: 2022 $4.9M for 374,061 services; 2023 $4.5M for 334,005 services; 2024 $4.9M for 374,094 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,137 | 336 | $5.82 | $12K |
| 85025 Blood Count | 2,088 | 326 | $7.47 | $16K |
Medicare prescription drug claims, 2024
In 2024, the drug Ghassan M Jano prescribed most often to Medicare patients was Ondansetron Hcl, with 49 prescriptions and refills. In total Ghassan M Jano wrote 721 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 49 | 49 | 31 | $3,498 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 43 | 43 | 21 | $1,129 |
| Eliquis Apixaban | 40 | 50 | Under 11 | $29K |
| Anastrozole Generic | 37 | 101 | 12 | $588 |
| Gabapentin Generic | 35 | 43 | 11 | $379 |
| Keytruda Pembrolizumab | 33 | 33 | Under 11 | $347K |
| Hydroxyurea Generic | 28 | 76 | Under 11 | $557 |
| Jakafi Ruxolitinib Phosphate | 25 | 25 | Under 11 | $417K |
| Ondansetron Odt Ondansetron | 22 | 23 | 11 | $385 |
| Enhertu Fam-Trastuzumab Deruxtecn-Nxki | 16 | 16 | Under 11 | $219K |
| Indomethacin Generic | 15 | 15 | Under 11 | $170 |
| Prednisone Generic | 15 | 16 | Under 11 | $88.67 |
| Alprazolam Generic | 13 | 13 | Under 11 | $15.53 |
| Xarelto Rivaroxaban | 13 | 37 | Under 11 | $20K |
| Tecentriq Atezolizumab | 13 | 13 | Under 11 | $136K |
Brand drugs: 255 claims; generic drugs: 466 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghassan M Jano $3,833 ($3,833 in general payments such as food, travel and fees) from 51 companies. The largest payer was Novartis Pharmaceuticals Corporation with $447.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $447 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $227 |
| Pfizer Inc. PFE | 14 | $215 |
| Abbvie Inc. ABBV | 9 | $211 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $209 |
| Celgene Corporation BMY | 9 | $168 |
| Gilead Sciences, Inc. GILD | 6 | $140 |
| GlaxoSmithKline, LLC. GSK | 7 | $140 |
| Intuitive Surgical, Inc. ISRG | 1 | $127 |
| Array Biopharma Inc PFE | 7 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.